This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dajcs, J. J.
Right arrow Articles by O'Callaghan, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dajcs, J. J.
Right arrow Articles by O'Callaghan, R. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2004, p. 1948-1952, Vol. 48, No. 6
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.6.1948-1952.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Effectiveness of Ciprofloxacin, Levofloxacin, or Moxifloxacin for Treatment of Experimental Staphylococcus aureus Keratitis

Joseph J. Dajcs, Brett A. Thibodeaux, Mary E. Marquart, Dalia O. Girgis, Mullika Traidej, and Richard J. O'Callaghan*

Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana

Received 10 November 2003/ Returned for modification 20 January 2004/ Accepted 10 February 2004

The purpose of this study was to quantitatively compare, in a rabbit keratitis model, the levels of effectiveness of moxifloxacin, levofloxacin, and ciprofloxacin for the treatment of Staphylococcus aureus isolates of diverse antibiotic susceptibilities. Rabbit eyes were intrastromally injected with approximately 100 CFU of methicillin-sensitive or methicillin-resistant S. aureus (MSSA or MRSA, respectively) organisms that were either sensitive or resistant to ofloxacin. One drop of moxifloxacin (0.5%), levofloxacin (0.5%), or ciprofloxacin (0.3%) was topically applied hourly from 4 to 9 (early) or 10 to 15 (late) h postinfection. At 1 h after cessation of therapy, the corneas were harvested, and the number of CFU per cornea was determined. For the ofloxacin-sensitive strains, early treatment of MSSA or MRSA with moxifloxacin, levofloxacin, or ciprofloxacin produced approximately a 5-log decrease in CFU per cornea relative to that in untreated eyes (P <= 0.0001). For late therapy of ofloxacin-sensitive strains, moxifloxacin, levofloxacin, and ciprofloxacin produced approximately 5-, 4-, and 2- to 3-log reductions in CFU per cornea, respectively (P <= 0.0001). Early treatment of the ofloxacin-resistant strains with either moxifloxacin or levofloxacin produced a >=4-log or >=3-log decrease, respectively, in the MSSA or MRSA strains (P <= 0.0001), whereas ciprofloxacin treatment produced a 1-log decrease in CFU per cornea relative to that in untreated eyes (P = 0.1540). For late treatment of ofloxacin-resistant strains, levofloxacin and ciprofloxacin failed to significantly reduce the number of CFU per cornea (P >= 0.3627), whereas moxifloxacin produced a significant reduction in CFU per cornea of approximately 1 log (P <= 0.0194). Therefore, for three of the four treatments tested, moxifloxacin demonstrated greater effectiveness than either levofloxacin or ciprofloxacin.

* Corresponding author. Mailing address: Department of Microbiology, Immunology, and Parasitology, LSU Health Sciences Center, 1901 Perdido St., New Orleans, LA 70112. Phone: (504) 568-4072. Fax: (504) 568-2918. E-mail: rocall{at}lsuhsc.edu.

Antimicrobial Agents and Chemotherapy, June 2004, p. 1948-1952, Vol. 48, No. 6
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.6.1948-1952.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hoshi, S., Kikuchi, K., Sasaki, T., Sotozono, C., Kinoshita, S., Hiramatsu, K. (2008). Postantibiotic Effects and Bactericidal Activities of Levofloxacin and Gatifloxacin at Concentrations Simulating Those of Topical Ophthalmic Administration against Fluoroquinolone-Resistant and Fluoroquinolone-Sensitive Methicillin-Resistant Staphylococcus aureus Strains. Antimicrob. Agents Chemother. 52: 2970-2973 [Abstract] [Full Text]  
  • Ferrer, C, Rodriguez, A, Abad, J L, Fernandez, J, Alio, J L (2008). Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis. Br. J. Ophthalmol. 92: 678-682 [Abstract] [Full Text]  
  • Skiadas, I., Pefanis, A., Papalois, A., Kyroudi, A., Triantafyllidi, H., Tsaganos, T., Giamarellou, H. (2007). Dexamethasone as Adjuvant Therapy to Moxifloxacin Attenuates Valve Destruction in Experimental Aortic Valve Endocarditis Due to Staphylococcus aureus. Antimicrob. Agents Chemother. 51: 2848-2854 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»